We have located links that may give you full text access.
CASE REPORTS
JOURNAL ARTICLE
REVIEW
Lymphoepithelioma-like carcinoma of the skin treated by Mohs micrographic surgery.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.] 1995 August
BACKGROUND: Lymphoepithelioma-like carcinoma of the skin (LELCS) is a rare malignant tumor thought to be of adnexal origin. Because of its rarity, treatment parameters have not been defined.
OBJECTIVE: To examine the role and success of Mohs micrographic surgery in the treatment of LELCS versus other forms of treatment previously documented in the literature.
METHODS/RESULTS: A review of the previous reported cases and their treatment outcomes was compared with the present case. Three of the 12 previously reported cases were incompletely treated with initial surgical management, with one patient subsequently dying of metastatic tumor. The present case was treated with Mohs micrographic surgery for recurrent LELCS, following initial treatment with electrodessication and curettage, and is without evidence of disease 20 months postoperatively.
CONCLUSION: LELCS may be successfully treated by Mohs micrographic surgery.
OBJECTIVE: To examine the role and success of Mohs micrographic surgery in the treatment of LELCS versus other forms of treatment previously documented in the literature.
METHODS/RESULTS: A review of the previous reported cases and their treatment outcomes was compared with the present case. Three of the 12 previously reported cases were incompletely treated with initial surgical management, with one patient subsequently dying of metastatic tumor. The present case was treated with Mohs micrographic surgery for recurrent LELCS, following initial treatment with electrodessication and curettage, and is without evidence of disease 20 months postoperatively.
CONCLUSION: LELCS may be successfully treated by Mohs micrographic surgery.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app